Drug intelligence / Profile preview

segesterone

Development stage
Phase 3
Lead developer
Population Council
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Vaginal, Implant
01

Overview

Segesterone (commonly used as its acetate ester, segesterone acetate) is a potent synthetic progestin of the 19-norprogesterone class. It acts as a high-affinity agonist of the progesterone receptor with minimal activity at androgenic, estrogenic, or mineralocorticoid receptors. Segesterone is primarily used in hormonal contraceptives—most notably in combination with ethinyl estradiol as a vaginal ring (e.g., Annovera)—and for the treatment of endometriosis in some countries. Due to rapid hepatic metabolism and lack of oral bioavailability, it is administered via non-oral routes such as implants or vaginal rings. The drug was developed by the Population Council and has been licensed to companies including TherapeuticsMD for commercial distribution[4][5][6].

Brand names
NestoroneElcometrine
Other names
segesterone acetateSGA
02

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on segesterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on segesterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call